
Growth equity · Growth stage · Est. 1990
Galen Partners
Galen Partners is a Stamford, Connecticut investor that works only in healthcare and specializes in growth equity. It has backed healthcare companies since 1990.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Galen Partners right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Galen Partners joined, from press and the firm’s own posts.
Every round Galen Partners joined
Round sizes, Galen Partners’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Galen Partners backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Galen Partners
Events where Galen Partners’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Galen Partners is based in the United States. It also has an office in Stamford.
In 1990.
8 fund vehicles are on public registers (SEC adviser filings), including GALEN PARTNERS VI, L.P., GALEN PARTNERS V, L.P. and GALEN EVOLVE SPV LLC.
Stages: Growth. Sectors: Medtech, Biotech. From the firm’s own website.
Galen expects healthcare to change more in the next decade than in the past fifty years. It backs proven, scaling healthcare companies that improve outcomes, lower cost, or both, and supports them through a hands-on approach it calls Collaborative Capital. From the firm’s own website.
Galen Partners lists 11 portfolio companies on its website, including Acura Pharmaceuticals, Aperio, Cambrooke Medical Foods, Dow Pharmaceutical Sciences and Encore Medical.
Firms whose websites list some of the same companies include Data Point Capital, Jump Capital and Output Capital.
Know before Galen Partners’s next round is announced.
PRO tracks Galen Partners’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.